Developer docs
API playgroundTry for free, no card

Search company profiles

Mevo

Full company profile

uuid0000k6j

Namestring
Mevo
Legal namestring
Mevo
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Mevo is a Brazilian healthtech company founded in 2017 and headquartered in São Paulo that operates a digital prescription and online pharmacy platform. The company addresses structural inefficiencies in Brazil's healthcare system, where roughly 150 million people manage approximately one billion handwritten prescriptions annually. Its core product, Mevo Receita Digital, enables healthcare providers to issue electronic prescriptions delivered to patients via SMS or WhatsApp, replacing paper-based workflows. The platform is integrated into more than 1,100 healthcare institutions and connected to seven major health insurance providers representing approximately 30% of Brazil's private healthcare market.

Beyond digital prescriptions, Mevo extends its ecosystem through Mevo Farma, an online pharmacy enabling patients to purchase medications digitally with home delivery, and Mevo Dispensação, a pharmacy-side module for verifying and dispensing digital prescriptions. Together these products span the connected patient journey—consultation, prescription issuance, exam scheduling, fulfillment, and dispensing. The April 2025 acquisition of Receita Digital further consolidated the provider-side footprint and prescription issuance capabilities.

Mevo's business model combines B2B platform revenue from healthcare institutions and insurance providers with transaction-based revenue from its online pharmacy (Mevo Farma). Its go-to-market is sales-led, relying on direct enterprise partnerships with hospitals, clinics, telemedicine platforms, and health insurers; on the consumer side, patients receive digital prescriptions and can purchase medications online, subject to Brazilian controlled-substance regulations (Portaria 344). The company has raised approximately R$340 million (~$68M USD) in cumulative funding across multiple rounds, with a March 2026 round led by Prosus.

Short descriptiontext

Mevo is a Brazilian healthtech operating a digital prescription platform integrated into 1,100+ healthcare institutions and 7 major insurance providers covering ~30% of Brazil's private market, complemented by an online pharmacy (Mevo Farma) and pharmacy dispensing module serving patients, providers, and insurers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersSão Paulo, Brazil
HQ citystring
São Paulo
HQ countrystring
Brazil
HQ regionstring
Latin America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital prescription platform, healthcare SaaS Brazil, e-prescription software, online pharmacy services, telemedicine prescription
Industry3 codes
PRIMARYHLALABAL
Virtual Pharmacy & Medication Management Integration Platforms
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
SECONDARYHLALAIAA
DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription)
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
SECONDARYHLALACAK
Pharmacy/Medication Management & Virtual MTM (Payer-Sponsored)
Healthcare & Life Sciences/Telehealth Platforms/Payer-Sponsored Virtual Care Platforms
NAICS code2 codes
  • Pharmacies and Drug Retailers456110
  • Ambulatory Health Care Services621
SIC code1 code
  • Retail-Drug Stores And Proprietary Stores5912
Product category
Digital Health Platform
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Digital Prescription Services
TypeSubscription Recurring
Description

Revenue generated from healthcare institutions and providers using Mevo's digital prescription platform. The platform serves as an entry point for a connected patient journey including exam scheduling, patient support programs, and online medication fulfillment.

prosus.com
2Online Pharmacy (Mevo Farma)
TypeTransaction Fee
Description

Transaction-based revenue from online medication sales and delivery services, allowing patients to purchase prescription medications digitally and receive them at their preferred location

mevo.com.br
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Brand1 of 2 records shown
1Mevo Receita Digital
Description

Digital prescription platform enabling healthcare providers to issue electronic prescriptions, and patients to receive prescriptions via SMS or WhatsApp.

mevo.com.br
+1 more record
Core offering1 text field

Mevo operates a digital prescription (e-prescription) SaaS platform that enables Brazilian healthcare professionals to issue electronic prescriptions delivered to patients via SMS or WhatsApp, replacing handwritten prescriptions. The platform is supplemented by Mevo Farma, an online pharmacy for direct medication purchase and home delivery, and Mevo Dispensação, a pharmacy-side solution for verifying and dispensing digital prescriptions. Together they form an integrated ecosystem connecting 1,100+ healthcare institutions, 7 major health insurers, pharmacies, and patients across Brazil.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 20 million patients projected to be treated via digital prescriptions in 2026
+2 more records
Product overview1 text field

Mevo is a Brazilian digital health platform offering an integrated ecosystem of healthcare solutions. The core offering is the Mevo Receita Digital platform for issuing and managing electronic medical prescriptions, which serves as the entry point for a connected patient journey. This core platform is supplemented by Mevo Farma (for online medication purchasing and delivery) and Mevo Dispensação (for pharmacy dispensing). The platform is integrated into over 1,100 healthcare institutions and connects patients, healthcare providers, hospitals, clinics, telemedicine services, and pharmacies across Brazil, with coverage through seven major health insurance providers representing approximately 30% of Brazil's private healthcare market.

Product and service1 record
1Mevo Receita Digital
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partner hospitals, clinics, and healthcare providers integrated into Mevo's digital prescription platform across Brazil.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Seven major health insurance providers covering approximately 30% of Brazil's private healthcare market, integrated with Mevo's platform.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Telemedicine platforms integrated with Mevo's digital prescription system enabling remote healthcare consultations.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Partner pharmacies that dispense medications using Mevo's digital prescription verification system.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Sami
TypeEmerging player
Description

Sami is a Brazilian healthtech offering a vertically integrated health plan with digital care delivery. It overlaps with Mevo in building connected patient journeys and digital prescription for its members.

2GoodRx
TypeBroad incumbent
Description

GoodRx is a US prescription price-transparency and online pharmacy platform. Its model of routing digital prescriptions into a captive pharmacy network parallels Mevo Receita Digital + Mevo Farma at a larger, mature scale.

TypeDirect peer
Description

Memed is Brazil's other leading digital prescription platform, directly competing with Mevo Receita Digital by digitising handwritten prescriptions and connecting prescribers, patients and pharmacies across the country.

TypeDirect peer
Description

Conexa Saúde is a Brazilian telehealth and integrated care platform with overlapping use cases in teleconsultation, e-prescription and patient journey management, competing with Mevo's provider-integrated model.

TypeBroad incumbent
Description

Pague Menos is a major Brazilian pharmacy chain with growing e-commerce and digital health ambitions, comparable to Mevo Farma on the medication delivery side of the value chain.

TypeEmerging player
Description

Alice is a Brazilian health plan with a strong digital-first care experience, including telemedicine and prescription management — a comparable end-to-end digital care model to Mevo's integrated ecosystem.

TypeBroad incumbent
Description

DASA is Brazil's largest medical diagnostics company with integrated digital health services. It overlaps with Mevo in connected patient journeys (exams, prescriptions) for private healthcare consumers.

TypeBroad incumbent
Description

RD is Brazil's largest pharmacy retail chain with its own digital platforms and customer base. It is a broad incumbent that competes with Mevo Farma on medication fulfillment and could build competing e-prescription rails.

TypeEmerging player
Description

Hims & Hers is a US DTC telehealth company with an integrated online pharmacy. It mirrors Mevo Farma's cash-pay, subscription-enabled online pharmacy model combined with tele-prescribing.

TypeDirect peer
Description

Portal Telemedicina operates a Brazilian telemedicine and digital diagnostics platform that issues prescriptions and exam orders remotely, overlapping with Mevo's prescription and exam-scheduling workflows.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors11 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Mevo

Digital Health Platformmevosaude.com.br

Mevo is a Brazilian healthtech operating a digital prescription platform integrated into 1,100+ healthcare institutions and 7 major insurance providers covering ~30% of Brazil's private market, complemented by an online pharmacy (Mevo Farma) and pharmacy dispensing module serving patients, providers, and insurers.

What Mevo does

Mevo is a Brazilian healthtech company founded in 2017 and headquartered in São Paulo that operates a digital prescription and online pharmacy platform. The company addresses structural inefficiencies in Brazil's healthcare system, where roughly 150 million people manage approximately one billion handwritten prescriptions annually. Its core product, Mevo Receita Digital, enables healthcare providers to issue electronic prescriptions delivered to patients via SMS or WhatsApp, replacing paper-based workflows. The platform is integrated into more than 1,100 healthcare institutions and connected to seven major health insurance providers representing approximately 30% of Brazil's private healthcare market.

Beyond digital prescriptions, Mevo extends its ecosystem through Mevo Farma, an online pharmacy enabling patients to purchase medications digitally with home delivery, and Mevo Dispensação, a pharmacy-side module for verifying and dispensing digital prescriptions. Together these products span the connected patient journey—consultation, prescription issuance, exam scheduling, fulfillment, and dispensing. The April 2025 acquisition of Receita Digital further consolidated the provider-side footprint and prescription issuance capabilities.

Mevo's business model combines B2B platform revenue from healthcare institutions and insurance providers with transaction-based revenue from its online pharmacy (Mevo Farma). Its go-to-market is sales-led, relying on direct enterprise partnerships with hospitals, clinics, telemedicine platforms, and health insurers; on the consumer side, patients receive digital prescriptions and can purchase medications online, subject to Brazilian controlled-substance regulations (Portaria 344). The company has raised approximately R$340 million (~$68M USD) in cumulative funding across multiple rounds, with a March 2026 round led by Prosus.

Mevo firmographics

Firmographics
Name
Mevo
Legal name
Mevo
Website
https://mevosaude.com.br
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
101–250 employees
Short description
Mevo is a Brazilian healthtech operating a digital prescription platform integrated into 1,100+ healthcare institutions and 7 major insurance providers covering ~30% of Brazil's private market, complemented by an online pharmacy (Mevo Farma) and pharmacy dispensing module serving patients, providers, and insurers.
Ownership category
akta.pro rank

Mevo industry classification

Industry
Product category
Digital Health Platform
NAICS
Pharmacies and Drug Retailers (456110), Ambulatory Health Care Services (621)
SIC
Retail-Drug Stores And Proprietary Stores (5912)
akta.pro industry
PRIMARYHLALABAL
Virtual Pharmacy & Medication Management Integration Platforms
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
SECONDARYHLALAIAA
DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription)
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
SECONDARYHLALACAK
Pharmacy/Medication Management & Virtual MTM (Payer-Sponsored)
Healthcare & Life Sciences/Telehealth Platforms/Payer-Sponsored Virtual Care Platforms

Keywords

  • Digital prescription platform
  • Healthcare SaaS Brazil
  • E-prescription software
  • Online pharmacy services
  • Telemedicine prescription

Where Mevo is headquartered

Location

Headquarters

HQ city
São Paulo
HQ country
Brazil
HQ region
Latin America

Offices1 record

Markets served

Mevo business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

  1. Digital Prescription Services: Revenue generated from healthcare institutions and providers using Mevo's digital prescription platform. The platform serves as an entry point for a connected patient journey including exam scheduling, patient support programs, and online medication fulfillment.
  2. Online Pharmacy (Mevo Farma): Transaction-based revenue from online medication sales and delivery services, allowing patients to purchase prescription medications digitally and receive them at their preferred location

Go-to-market motion1 record

Distribution channels4 records

Marketing channels2 records

Mevo product offering

Product offering

Core offering

Mevo operates a digital prescription (e-prescription) SaaS platform that enables Brazilian healthcare professionals to issue electronic prescriptions delivered to patients via SMS or WhatsApp, replacing handwritten prescriptions. The platform is supplemented by Mevo Farma, an online pharmacy for direct medication purchase and home delivery, and Mevo Dispensação, a pharmacy-side solution for verifying and dispensing digital prescriptions. Together they form an integrated ecosystem connecting 1,100+ healthcare institutions, 7 major health insurers, pharmacies, and patients across Brazil.

Product overview

Mevo is a Brazilian digital health platform offering an integrated ecosystem of healthcare solutions. The core offering is the Mevo Receita Digital platform for issuing and managing electronic medical prescriptions, which serves as the entry point for a connected patient journey. This core platform is supplemented by Mevo Farma (for online medication purchasing and delivery) and Mevo Dispensação (for pharmacy dispensing). The platform is integrated into over 1,100 healthcare institutions and connects patients, healthcare providers, hospitals, clinics, telemedicine services, and pharmacies across Brazil, with coverage through seven major health insurance providers representing approximately 30% of Brazil's private healthcare market.

Differentiator

Problem solved

Functional benefit

Brands

  • Mevo Receita Digital: Digital prescription platform enabling healthcare providers to issue electronic prescriptions, and patients to receive prescriptions via SMS or WhatsApp.
  • Mevo Farma

Products and services

  • Mevo Receita Digital

Quantifiable outcome

  • 20 million patients projected to be treated via digital prescriptions in 2026
  • +2 more outcomes

Companies that use Mevo

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Mevo technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Mevo partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core.

  • Healthcare Institutions (1,100+)coreStrategic or Co-development PartnerPartner hospitals, clinics, and healthcare providers integrated into Mevo's digital prescription platform across Brazil.
  • Health Insurance Providers (7 major)coreStrategic or Co-development PartnerSeven major health insurance providers covering approximately 30% of Brazil's private healthcare market, integrated with Mevo's platform.
  • Telemedicine PlatformscoreStrategic or Co-development PartnerTelemedicine platforms integrated with Mevo's digital prescription system enabling remote healthcare consultations.
  • Pharmacy PartnerscoreChannel Partner/ Reseller/ DistributorPartner pharmacies that dispense medications using Mevo's digital prescription verification system.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Mevo competitors and assessment

Company assessment

Emerging players

  • Sami: Sami is a Brazilian healthtech offering a vertically integrated health plan with digital care delivery. It overlaps with Mevo in building connected patient journeys and digital prescription for its members.
  • Alice: Alice is a Brazilian health plan with a strong digital-first care experience, including telemedicine and prescription management — a comparable end-to-end digital care model to Mevo's integrated ecosystem.
  • Hims & Hers Health: Hims & Hers is a US DTC telehealth company with an integrated online pharmacy. It mirrors Mevo Farma's cash-pay, subscription-enabled online pharmacy model combined with tele-prescribing.

Broad incumbents

  • GoodRx: GoodRx is a US prescription price-transparency and online pharmacy platform. Its model of routing digital prescriptions into a captive pharmacy network parallels Mevo Receita Digital + Mevo Farma at a larger, mature scale.
  • Pague Menos: Pague Menos is a major Brazilian pharmacy chain with growing e-commerce and digital health ambitions, comparable to Mevo Farma on the medication delivery side of the value chain.
  • DASA: DASA is Brazil's largest medical diagnostics company with integrated digital health services. It overlaps with Mevo in connected patient journeys (exams, prescriptions) for private healthcare consumers.
  • Raia Drogasil (RD): RD is Brazil's largest pharmacy retail chain with its own digital platforms and customer base. It is a broad incumbent that competes with Mevo Farma on medication fulfillment and could build competing e-prescription rails.

Direct peers

  • Memed: Memed is Brazil's other leading digital prescription platform, directly competing with Mevo Receita Digital by digitising handwritten prescriptions and connecting prescribers, patients and pharmacies across the country.
  • Conexa Saúde: Conexa Saúde is a Brazilian telehealth and integrated care platform with overlapping use cases in teleconsultation, e-prescription and patient journey management, competing with Mevo's provider-integrated model.
  • Portal Telemedicina: Portal Telemedicina operates a Brazilian telemedicine and digital diagnostics platform that issues prescriptions and exam orders remotely, overlapping with Mevo's prescription and exam-scheduling workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Mevo social profiles

Digital presence

Mevo financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Mevo leadership team

Management profile

Number of profiles

Profiles1 record

Mevo funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors11 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Mevo M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mevo

What does Mevo do?

Mevo operates a digital prescription (e-prescription) SaaS platform that enables Brazilian healthcare professionals to issue electronic prescriptions delivered to patients via SMS or WhatsApp, replacing handwritten prescriptions. The platform is supplemented by Mevo Farma, an online pharmacy for direct medication purchase and home delivery, and Mevo Dispensação, a pharmacy-side solution for verifying and dispensing digital prescriptions. Together they form an integrated ecosystem connecting 1,100+ healthcare institutions, 7 major health insurers, pharmacies, and patients across Brazil.

Is Mevo a public or private company?

Mevo is a private company. It is classified as venture growth investor backed and is currently operating.

When was Mevo founded?

Mevo was founded in 2017. It employs 101 to 250 people.

Where is Mevo based?

Mevo is headquartered in São Paulo, Brazil, in the Latin America region.

How does Mevo make money?

Two revenue lines are on record. Digital Prescription Services are the primary driver. The others are online Pharmacy (Mevo Farma).

Who are Mevo's main competitors?

Emerging players on record are Sami, Alice and Hims & Hers Health. Broad incumbents are GoodRx, Pague Menos, DASA and Raia Drogasil (RD). Direct peers are Memed, Conexa Saúde and Portal Telemedicina.

Does Mevo have an API?

No public API is recorded for Mevo.

What industry is Mevo in?

Mevo's product category is Digital Health Platform. Its primary akta.pro industry code is HLALABAL, Virtual Pharmacy & Medication Management Integration Platforms, with a secondary code of HLALAIAA, DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription). Its NAICS code is 456110 and its SIC code is 5912.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Brazil JournalO Brasil prometeu criar o Open Health. O dr. consulta está oferecendo um atalhodr.consulta is developing a patient health wallet to reduce duplicate exams and consultations, with FINEP providing R$21 million and the company R$9 million. The project aims to integrate with the government's Open Health initiative. The company plans to open up to three new units this year in São Paulo and four in Rio de Janeiro.LatamlistMevo raises $18M round led by ProsusBrazilian digital prescription platform Mevo raised $18 million in a funding round led by Prosus, with participation from Matrix, Jefferson River Capital, and Floating Point. The company, founded in 2017, connects doctors, patients, pharmacies, and pharmaceutical companies through its platform and has expanded into exam scheduling and online medication fulfillment. Mevo will use the funds to expand exam scheduling, integrate patient support programs, and grow its online pharmacy operations, having already integrated with over 1,100 healthcare institutions and seven major health insurance providers covering approximately 30% of Brazil's private healthcare market.Brazil JournalMevo levanta R$ 95 milhões para escalar a receita digitalMevo, a Brazilian digital prescription startup, raised R$ 95 million in a funding round led by Prosus, with participation from existing investors including Matrix Partners, Jefferson River Capital, and Lyrical Partners. The company, which has now raised a total of R$ 340 million, will use the funds to hire 100 additional employees and accelerate growth across its business verticals. Mevo is present in approximately 1,100 hospital units and expects to generate 50 million prescriptions this year, up from 35 million in the previous year, with plans for a Series C round in about 18 months.ProsusMevo raises US$18m in funding round led by ProsusMevo, Brazil's leading e-prescription healthtech, raised US$18 million in a funding round led by Prosus, with participation from existing shareholders Matrix, Jefferson River, and Floating Point. The investment will accelerate the company's expansion of its digital prescription platform that serves as an entry point for a more connected patient journey, including exam scheduling, patient support programs, and online medication fulfillment. The company projects 20 million patients will be treated via Mevo's digital prescriptions in 2026, with its platform already integrated into over 1,100 healthcare institutions and seven major health insurance providers covering approximately 30% of Brazil's private healthcare market.FoleyFoley Represents Brazilian Healthtech Startup Mevo in $18M Funding RoundFoley & Lardner LLP represented Brazilian healthtech startup Mevo in an $18 million funding round led by Prosus, with additional participation from Matrix, Jefferson River, and Floating Point. Mevo operates Brazil's leading e-prescription platform, addressing inefficiencies in a healthcare system where over 150 million people manage approximately one billion handwritten prescriptions annually. The investment will accelerate Mevo's expansion of its connected patient journey services, including exam scheduling, patient support program integration, and online medication fulfillment.Towards HealthcareLatin America Healthtech Market Growth & Innovation 2025Latin America's digital health market grew 37.6% to reach $35 billion in 2024, with AI-driven startups increasing by 6% between 2022 and 2024, and 52% of startups focusing on treatment, prevention, and diagnosis. Mexican healthtech startup Unima has served over 500,000 patients in rural areas with low-cost diagnostics, while Brazilian company Mevo raised $20 million in 2024 to expand its digital prescription platform. Companies including Colombia's 1DOC3, Brazil's Pura Mente, and TRAINFES are also advancing telemedicine and remote rehabilitation services, with Mexico and Brazil accounting for 78% of the region's healthtech startups.BP MoneyMevo anuncia aquisição da startup Receita DigitalMevo, a Brazilian digital prescription healthtech, acquired Receita Digital, a pioneer in electronic prescribing. The acquisition strengthens Mevo's strategy to expand its base of prescribing professionals. Mevo has integrated with over 700 health institutions and is used by 13 of 15 top hospitals.InfoMoneyLetra de médico nunca mais: ‘healthtech’ Mevo compra Receita DigitalMevo acquired Receita Digital, a digital prescription startup founded in 2017, to expand its base of health professionals. Mevo's app is integrated with 700 health institutions, including Sírio-Libanês and HCor, and the acquisition value was not disclosed.StartupsMevo compra startup Receita Digital após série B de R$ 140MMevo, a digital prescription healthtech, acquired Receita Digital on Wednesday, with the deal value undisclosed. The acquisition follows Mevo's Series B of R$140M, led by Matrix, and aims to expand its network of prescribing professionals. Mevo integrates with over 700 health institutions and is used by 13 of 15 top hospitals.PR NewswireMevo Raises $19 Million Series B Funding, Led by Matrix, to Scale Digital Prescriptions in Brazil, Bringing a Modern Experience to Customers and Creating More Access to HealthcareMevo raised $19M in Series B funding led by Matrix, with participation from Jefferson River Capital and others. The Brazilian digital prescription platform will use the funds to expand provider partnerships and enhance its platform. Mevo has served over 10 million patients and all 80,000+ Brazilian pharmacies.